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ACTIVE SEARCH FOR LEPROSY CASES IN MIDWESTERN BRAZIL:  
A SEROLOGICAL EVALUATION OF ASYMPTOMATIC HOUSEHOLD CONTACTS  
BEFORE AND AFTER PROPHYLAXIS WITH BACILLUS CALMETTE-GUÉRIN
Omesina Maroja LIMEIRA(1), Ciro Martins GOMES(1), Orlando Oliveira de MORAIS(1), Mariana Vicente CESETTI(2) & Rosicler Rocha Aiza ALVAREZ(1)
SUMMARY
Leprosy is a disease caused by Mycobacterium leprae that carries a high risk of disability, making early diagnosis mandatory. 
This study aimed to determine the applicability of anti-PGL-1 IgM antibody detection, using the ML FLOW technique, as an assistant 
tool for the detection of leprosy infection in asymptomatic household contacts (AHHC) of multibacillary leprosy index cases from 
Midwest Brazil. Serological changes induced by the prophylaxis of these household contacts with Bacillus Calmette-Guérin (BCG) 
were also verified. A total of 91 AHHC were assessed, among which, 18.68% (n = 17) presented both positive bacilloscopy and positive 
anti-PGL-1 IgM serology. Positivity concordance between these two laboratorial exams (Kappa Index = 1; p < 0.001) was indicated, 
however, one case did not demonstrate concordance between the semiquantitative assessment of anti-PGL-1 IgM and the bacilloscopy 
index (Kappa Index = 0.96; p < 0.001). Among the 17 AHHC with positive bacilloscopy, eight were reassessed after prophylaxis with 
BCG and two of them presented negative anti-PGL-1 IgM serology, being these patients who had presented a bacilloscopy index of < 
2[+] in the initial assessment. This study shows that anti-PGL-1 IgM detection may be used as a tool to determine the bacillary load 
in AHHC and to detect immune changes related to prophylaxis by nonspecific vaccination.
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INTRODUCTION
Leprosy is a chronic infectious disease that is caused by M. leprae, 
an obligate intracellular mycobacterium. Leprosy has a long incubation 
period and mainly affects the skin and nerves; however, a broad spectrum 
of clinical manifestations may be present. Early disease recognition 
is essential to prevent neural damage, usually associated with a late 
diagnosis and adverse outcomes20. 
Currently, the evaluation of household contacts of multibacillary 
leprosy patients is routinely conducted via clinical examination19. 
However, this approach depends on qualified human resources and is 
subject to variation depending on examiner experience and qualification8. 
Recent studies using sensitive laboratory techniques have demonstrated 
that approximately 18% of household contacts of leprosy patients 
may also be infected by M. leprae and may develop the disease2. This 
index can be as high as 50% when only the household contacts of 
multibacillary patients are considered2,7. The current approach used to 
prevent transmission is the early administration of multidrug therapy 
in multibacillary cases, since prophylaxis against leprosy is still under 
debate and no specific vaccine against M. leprae is available20. Passive 
immunization with Bacillus Calmette-Guérin (BCG) is indicated for 
asymptomatic contacts and offers variable levels of protection3.
Clinical trials conducted on household contacts in order to detect new 
cases of leprosy are of great importance. Many clinical and laboratorial 
methods for the diagnosis of leprosy have been investigated. Phenolic 
glycolipid-1 (PGL-1) is an antigen specific to M. leprae that induces 
the formation of the IgG and IgM class antibodies13. PGL-1 is found in 
high concentrations in the serum and tissues of untreated multibacillary 
patients and is involved in the strong humoral response seen in patients 
with the lepromatous form of the disease13.
The detection of antibodies against PGL-1 (anti-PGL-1) has been 
widely studied as an approach for leprosy diagnosis. When evaluating 
contacts of leprosy patients, anti-PGL-1 positivity has been associated 
with passive transmission, which is an indicator of the prevalence of the 
disease7,9. Various laboratorial techniques for the detection of anti-PGL-1 
antibodies are available, although the ML FLOW method, besides being 
easy to implement in daily clinical practice, has shown similar sensitivity 
and specificity to the ELISA method when tested as a diagnostic tool in 
a leprosy endemic population13.
This study aimed to determine the applicability of the ML FLOW 
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technique in the diagnosis of leprosy in asymptomatic household contacts 
(AHHC) of multibacillary index cases from Midwestern Brazil, by means 
of the concordance between the ML FLOW test and bacilloscopy. A 
serological analysis of immune changes initiated after immunogenic 
stimulus with BCG vaccination was also performed.
MATERIAL AND METHODS
This study was conducted with household contacts of multibacillary 
leprosy patients who attended the dermatology clinic at the Brasilia 
University Hospital (Brazil) from March 2006 to October 2006. After 
each diagnosis of a patient having multibacillary leprosy, following the 
World Health Organization (WHO) criteria, their household contacts 
were actively catalogued, contacted and invited to take part in the study. 
The index cases were not included in this study. 
All of the household contacts who agreed to participate in the study 
were questioned and examined by a dermatologist with regards to signs 
or symptoms of cutaneous or neural leprosy. Clinical examination 
consisted of a complete examination of the skin, nerve palpation, 
temperature and pain sensitivity test of extremities and any suspicious 
lesion. Specific neurological exams such as electroneuromyography 
and microfilaments tests were not employed because they are not 
routine screening tools and because they usually show only signs of 
late onset diseases. All household contacts were classified as AHHC 
of multibacillary leprosy index cases and finally included in the study 
if they lacked any signs of infection after inquiry and dermatological 
examination3,20. The intent to participate was formalized through a free 
and informed consent form, which was signed by all of the patients. 
The study is in accordance with the Helsinki Declaration, as revised 
in 1983.
All the selected AHHC were submitted to dermal cell scraping 
and blood samples collection for bacilloscopy and ML FLOW testing, 
respectively. Next, all the contacts received prophylaxis with one 
dose of BCG, in accordance with the Brazilian’s Health Ministry 
recommendations. In addition, they were instructed to return to the 
dermatology clinic after approximately 30 days for a new clinical 
evaluation and for checking test. All those contacts who attended the 
30-day follow-up visit had new samples collected if they had presented 
positive bacilloscopy or positive ML FLOW serology in the first 
samples. Resample of contacts who showed positive bacilloscopy and 
did not attend the follow-up visit was not performed; however, they 
were actively pursued by health authorities for the immediate initiation 
of leprosy treatment.
Dermal cell scraping samples for bacilloscopy were always collected 
by experienced professionals, from at least four sites, e.g. earlobes, 
one elbow, and one lesion. In the absence of lesions, the collection 
was performed in the following areas: earlobes, elbows, and knees4. 
Bacilloscopy sample analysis was performed by the Public Health’s 
Central Laboratory at Brasilia (LACEN-DF), a public agency on behalf 
of the Health Secretariat of the Brazilian Federal District, which is the 
national reference laboratory for the analysis of this kind of samples. The 
sample analysis technique consisted of five steps: collection, fixation, 
Ziehl-Neelsen staining, microscopy, reading, and interpretation. The 
results were expressed on a scale that ranged from 0 to 6 according to 
Ridley’s logarithmic scale4.
The ML FLOW test results were recorded using qualitative (positive 
or negative) and semiquantitative (0[+], 1[+], 2[+], 3[+], and 4[+]) scores. 
Testing was carried out using a semisynthetic antigen containing natural 
trisaccharide linked to bovine serum albumin (natural trisaccharide-
phenylpropionate-bovine serum albumin or NT-P-BSA)5,12.
IBM® SPSS®, v.18.0, was used for the analysis of descriptive data 
and concordance evaluation. Also, the OpenEpi, v.2.3.1, was used to 
calculate sensibility, specificity, predictive and accuracy values. The 
statistical analysis assigned priority to the qualitative and quantitative 
concordance of the ML FLOW test and bacilloscopy, by using the Kappa 
index. The significance level was considered 5%, and the confidence 
interval (CI), 95%.
RESULTS
A total of 91 AHHC of multibacillary leprosy index cases were 
evaluated. Overall, the mean age was 32.68 ± 17.01 years; 49.45% were 
aged between 15 to 40 years; 15 (16.48%) were up to 15 years-old; and 
25 (27.47%) were of male gender.
Among the 91 AHHC evaluated, a total of 18.68% (n = 17) patients 
tested positive for leprosy according to both the ML FLOW and 
bacilloscopy results. Regarding a qualitative analysis, there was 100% 
(n = 17) concordance between the tests. (Kappa Index = 1; p < 0.001) 
(Table 1). However, the tests only showed concordant quantitative results 
in 16 patients (Kappa Index = 0.96; p < 0.001). There was no quantitative 
correlation between tests only in one case, even though both exams 
resulted positive (Table 2).
Most of the AHHC with positive bacilloscopy and ML FLOW were 
male (n = 12), and none of them were under 15 years of age. However, 
positivity was detected in three patients who were 15 to 25 years of age, 
eight patients who were 26 to 39 years of age, three patients who were 
40 to 59 years of age, and three patients who were 60 years of age or 
more. Sensitivity (95% CI 0.81-1), specificity (95% CI 0.95-1), negative 
(95% CI 0.96-1) and positive (95% CI 0.81-1) predictive values, and 
diagnostic accuracy (95% CI 0.96-1) of ML FLOW test were complete 
(100%), although there was no statistical significance. 
Although there was no clinical signs of leprosy, the AHHC who 
Table 1





n % n % n %
Positive 17 100 0 0 17 18.68
Negative 0 0 74 100 74 81.31
Total 17 100 74 100 91 100
Kappa Index = 1; Standard error = < 0.001; p < 0.001. Wilson Score: Sensitivity 
100%(95% CI 0.81-1), specificity 100%(95% CI 0.95-1), positive Predictive 
Value 100%(95% CI 0.81-1), negative predictive value 100%(95% CI 0.96-1), 
diagnostic accuracy 100% (95% CI 0.96-1).
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presented positive skin smears were classified as multibacillary leprosy 
patients according to WHO recommendations20. From the 17 household 
contacts with positive results, only eight attended the 30-day follow-up 
visit and underwent a resample collection. For all these patients, the 
new bacilloscopy results were 100% consistent with first sample results. 
However, new ML FLOW testing revealed only six patients maintained 
positive results (patients presenting initial BI greater than 2[+]), and two 
patients with negative results (patients presenting initial BI lower than 
2[+]). (Kappa Index = 0.86; p < 0.001) (Table 3). All the 17 multibacilary 
AHHC received treatment prescription for multibacillary leprosy after 
the first follow-up visit or after active search realized by local health 
authorities. 
DISCUSSION
Leprosy is a disease of insidious progression, which makes its 
detection difficult, particularly in patients with the lepromatous form. 
An infected patient can maintain the status of being a transmitter of 
leprosy for years before presenting any recognizable clinical sign2,8. 
Thus, strategies aiming for the early diagnosis of leprosy are of great 
importance. The use of isolated clinical examinations as a tool to early 
identify multibacillary patients is frequently subject of discussion8,14. 
Many new approaches have been employed with the aim of improving 
the diagnosis sensitivity and for optimizing the detection of multibacillary 
patients as well as in household contacts13.
Studies on ML FLOW testing have focused on the detection of new 
cases, principally among contacts, with the goal of endemic control8. 
The Brazilian Midwest is an endemic area for leprosy; therefore, 
epidemiological research that assesses the risk of contagion to the local 
population is of great value in determining surveillance policies. This 
study detected an 18.68% positive bacilloscopy and seropositivity among 
AHHC of multibacillary leprosy patients. Such a rate is comparable to 
that found in other Brazilian regions10.
The expressive amount of household contacts presenting no 
symptoms at clinical examination, even those who tested positive to 
anti-PGL-1 antibodies, surely emphasizes the limitations of the isolated 
clinical examination in the detection of leprosy cases, even multibacillary 
ones. This current study relied on clinical examination performed by 
dermatologists specialized in leprosy management working in a tertiary 
hospital, nevertheless clinical diagnostic failure was as high as reported. 
Otherwise, it must be stressed that in Brazil, the evaluation of contacts 
is mostly made at primary care institutions and often by professionals 
without medical formation, which may worsen the efficacy of the clinical 
examination17.
Clinical signs of leprosy are usually a result of the body immune 
response. This fact may help explain the lack of clinical recognition of 
the 17 multibacillary AHHC of our study, since these patients show a Th2 
bent immune response that may not be sufficient to fight the infection. 
These patients may present a long time of bacilli proliferation before 
recognizable clinical signs, even to trained eyes of specialists. 
In our study we evaluated only AHHC of multibacillary index cases. 
However, due to data limitations, we could not evaluate the rate of 
consanguinity between household contacts and index cases. Considering 
in-house transmission, we may expect a high rate of linear and collateral 
consanguinity between them. This information may also support the 
occurrence of higher rates of multibacillary disease among household 
contacts of multibacillary index cases, since they may share a similar 
specific immune response to leprosy, determined by the consanguinity 
relationship2.
ARAÚJO (2003) and other contemporary authors have demonstrated 
a directly proportional correlation between the intensity of ML FLOW 
test results and the bacillary load, especially among lepromatous patients1. 
These results demonstrate anti-PGL-1 serology as a good indicator of 
the bacillary load1,6,11,13,15. These findings are consistent with the data 
from literature showing anti-PGL-1 IgM positivity close to 100% in 
multibacillary cases12,13. These individuals classically exhibit an immune 
response that favors the Th2 pathway, which is usually insufficient 
for the destruction of the bacillus. Immune response in multibacillary 
disease determines the formation of high titers of antibodies, being the 
bacilloscopy and serological tests usually with concurrently positive 
results.
Table 2
Correlation of the results of the semiquantitative ML FLOW test and the 




0 [+]1 [+]2 [+]3 [+]4
0 74 0 0 0 0 74
1[+] 0 9 1 0 0 10
2[+] 0 0 3 0 0 3
3[+] 0 0 0 2 0 2
4[+] 0 0 0 0 2 2
5[+] 0 0 0 0 0 0
6[+] 0 0 0 0 0 0
Total 74 9 4 2 2 91
Kappa Index = 0.96; Standard error = 0.033; p < 0.001.
Table 3
Serological evolution and bacilloscopy evaluation in contacts of patients with 
multibacillary leprosy before and after vaccination with BCG
Patient
Pre-BCG vaccination Post-BCG vaccination
IB ML FLOW IB ML FLOW
1 ≥2 [+] [+] ≥2 [+] [+]
2 ≥2 [+] [+] ≥2 [+] [+]
3 ≥2 [+] [+] ≥2 [+] [+]
4 ≥2 [+] [+] ≥2 [+] [+]
5 ≥2 [+] [+] ≥2 [+] [+]
6 ≥2 [+] [+] ≥2 [+] [+]
7 <2 [+] [+] <2 [+] [-]
8 <2 [+] [+] <2 [+] [-]
Kappa Index = 0.96; Standard error = 0.082; p < 0.001.
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The negative trend of the ML FLOW results after BCG prophylaxis 
could have resulted from a more balanced immune response presented by 
the two patients presenting reduced bacillary loads (<2[+]). TABOURET 
et al. (2010) consider that the lipid constituents of M. leprae envelope are 
structurally similar to those of M. bovis BCG, except PGL18
. 
The same 
group reprogrammed the PGL biosynthesis pathway in M. bovis BCG. 
They stated that the construction of recombinant BCG producing PGL-1 
augments its infectivity and intracellular growth in human macrophages18. 
Therefore, the immune stimulus triggered by BCG without PGL-1 
antigens may have stimulated Th1 response, which caused a decrease in 
the anti-PGL-1 IgM titers and a negative trend in the results. Otherwise, 
the short time (30 days) for retesting surely was not sufficient for a 
negative trend in bacilloscopy. Ultimately, the ML FLOW result changes 
could be explained by a sensitivity variation inherent of any diagnostic 
test. Unfortunately, a qualitative bacillary evaluation was not performed 
on the second samples to estimate the bacilli viability in these patients. 
Several studies relate the reduction of anti-PGL-1 IgM antibodies to a 
decrease in bacillary antigenic stimulus and a transmission chain break9,16, 
which in our patients could have resulted from a smaller load of viable 
bacilli secondary to Th1 immune response activation.
Data from the Brazilian Leprosy Control Program showed that after 
the identification of leprosy index cases in the period of 2001 to 2007, 
only 50.6 % of their household contacts were submitted to a clinical 
examination17. This means that almost half of the contacts are not 
evaluated due to operational failures. Furthermore, many contacts, even 
multibacillary, may not be diagnosed after specialist’s evaluation due to 
the lack of recognizable clinical signs. Together, this data calls for the 
implementation of more suitable measures of surveillance, other than 
the clinical examination, which could promote easier and more effective 
identification of transmission sources. To change the actual scenario, the 
adoption of new diagnostic techniques seems imperative. It would allow 
for the early detection of multibacillary cases and prophylaxis, even in 
areas with persistence of small transmission foci, in countries where 
leprosy is virtually considered to be controlled8. 
This study is in accordance with previous data which shows the 
effectiveness of the ML FLOW test in the detection of multibacillary 
disease among asymptomatic contacts of multibacillary patients. The 
method demonstrated concordance with and a similar sensitivity to 
bacilloscopy. Therefore, we believe that the ML FLOW test is an approach 
that can assist in the diagnosis and classification of leprosy cases in high-
risk groups and in populations with a high prevalence, as previously 
recommended by other authors12. Prophylaxis with BCG is not specific for 
M. leprae, although it has been shown effective in modulating the immune 
response in several patients, and may reduce the number of patients who 
transmit the disease. This immune modulating role of BCG vaccination was 
probably the main stain for the changes on serology status of our patients, 
although new studies are necessary to confirm our findings. 
RESUMO
Busca ativa por casos de hanseníase no Centro-Oeste do Brasil: 
avaliação sorológica dos contatos domiciliares assintomáticos 
antes e após a profilaxia com Bacillus Calmette-Guérin
A hanseníase é doença causada pelo Mycobacterium leprae, 
apresentando elevado potencial incapacitante, o que torna indispensável 
seu diagnóstico precoce. O estudo visa determinar a aplicabilidade da 
detecção de anticorpos anti-PGL1-IgM por meio da técnica do ML 
FLOW como ferramenta adjuvante ao diagnóstico de hanseníase em 
contatos domiciliares assintomáticos (AHHC) de pacientes multibacilares 
procedentes da região Centro-Oeste do Brasil, bem como, documentar 
o comportamento sorológico após a profilaxia com a vacina Bacillus 
Calmette-Guérin (BCG). Foram avaliados 91 AHHC atendidos no Hospital 
Universitário de Brasília - Brasil, dos quais 18,68% (n = 17) apresentaram 
positividade para baciloscopia e anti-PGL1-IgM, totalizando uma 
concordância completa entre os dois grupos (Índice Kappa = 1; p < 0,001). 
Em apenas um dos casos não observou-se concordância entre a avaliação 
semi-quantitativa do anti-PGL1-IgM e índice baciloscópico (Índice 
Kappa = 0,96; p < 0,001). Oito dos 17 AHHC com baciloscopia positiva 
foram reavaliados após profilaxia com BCG e apenas dois apresentaram 
negativação dos títulos anti-PGL1-IgM, sendo tais casos correspondentes 
aos que haviam apresentado índice baciloscópico menor do que 2[+] na 
avaliação inicial. O estudo corrobora o potencial do anti-PGL1-IgM como 
ferramenta de predição da carga bacilar em AHHC da região Centro-Oeste 
do Brasil, e surpreende alterações imunes relacionadas à profilaxia obtida 
pela vacinação não específica com BCG.
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em área urbana. An Bras Dermatol. 2005;80(Suppl 3):301-6. 
 8.  Cardona-Castro N, Beltrán-Alzate JC, Romero-Montoya M. Clinical, bacteriological 
and immunological follow-up of household contacts of leprosy patients from a post-
elimination area - Antioquia, Colombia. Mem Inst Oswaldo Cruz. 2009;104:935-6.
 9.  Desforges S, Bobin P, Brethes B, Huerre M, Moreau JP, Bach MA. Specific anti-M. 
leprae PGL-1 antibodies and Mitsuda reaction in the management of household 
contacts in New Caledonia. Int J Lepr Other Mycobact Dis. 1989;57:794-800.
 10.  Frota CC, Freitas MV, Foss NT, Lima LN, Rodrigues LC, Barreto ML, et al. 
Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known 
contacts of leprosy in an endemic and a non-endemic area in northeast Brazil. Trans 
R Soc Trop Med Hyg. 2010;104:490-5.
LIMEIRA, O.M.; GOMES, C.M.; MORAIS, O.O.; CESETTI, M.V. & ALVAREZ, R.R.A. - Active search for leprosy cases in Midwestern Brazil: a serological evaluation of asymptomatic 
household contacts before and after prophylaxis with Bacillus Calmette-Guérin. Rev. Inst. Med. Trop. Sao Paulo, 55(3): 173-7, 2013. 
177
 11.  Lobato J, Costa MP, Reis E de M, Gonçalves MA, Spencer JS, Brennan PJ, et al. 
Comparison of three immunological tests for leprosy diagnosis and detection of 
subclinical infection. Lepr Rev. 2011;82:389-401.
 12.  Lyon S, Castorina da Silva R, Lyon AC, Grossi MA, Lyon SH, Azevedo M de L, et 
al. Association of the ML flow serologic test to slit skin smear. Rev Soc Bras Med 
Trop. 2008;41(Suppl 2):23-6.
 13.  Moura RS, Calado KL, Oliveira ML, Bührer-Sékula S. Leprosy serology using PGL-I: 
a systematic review. Rev Soc Bras Med Trop. 2008;41(Suppl 2):11-8.
 14.  Nagao-Dias AT, Almeida TL, Oliveira M de F, Santos RC, Lima AL, Brasil M. 
Salivary anti-PGL IgM and IgA titers and serum antibody IgG titers and avidities in 
leprosy patients and their correlation with time of infection and antigen exposure. 
Braz J Infect Dis. 2007;11:215-9. 
 15.  Parkash O, Kumar A, Pandey R, Nigam A, Girdhar BK. Performance of a lateral 
flow test for the detection of leprosy patients in India. J Med Microbiol. 2008;57(Pt 
1):130-2.
 16.  Saad MH, Medeiros MA, Gallo ME, Gontijo PP, Fonseca LS. IgM immunoglobulins 
reacting with the phenolic glycolipid-1 antigen from Mycobacterium leprae in sera 
of leprosy patients and their contacts. Mem Inst Oswaldo Cruz. 1990;85:191-4. 
 17.  Sampaio PP, Barbosa JC, Alencar MJF, Heukelbach J, Hinders D, Magalhães MCM, 
et al. Programa de controle da hanseníase no Brasil: avaliação por profissionais de 
saúde. Cad Saúde Colet., Rio de Janeiro. 2009;17:273-87.
 18.  Tabouret G, Astarie-Dequeker C, Demangel C, Malaga W, Constant P, Ray A, 
et al. Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. 
bovis BCG modulates early interaction with human phagocytes. PLoS Pathog. 
2010;6(10):e1001159.
 19.  Teixeira AC, Cruvinel DL, Roma FR, Luppino LF, Resende LH, Sousa T, et al. 
Evaluation of the agreement between clinical and laboratorial exams in the diagnosis 
of leprosy. Rev Soc Bras Med Trop. 2008;41(Suppl 2):48-55. 
 20.  World Health Organization. Global strategy for further reducing the leprosy burden 
and sustaining leprosy control activities 2006-2010. Operational guidelines. Regional 
Office for South-East Asia New Delhi. Lepr Rev. 2006;77(3):IX, X, 1-50.
Received: 6 May 2012
Accepted: 26 October 2012
LIBRARY OF THE 
SÃO PAULO INSTITUTE OF TROPICAL MEDICINE
Website: www.imt.usp.br/portal 
Address: Biblioteca do Instituto de Medicina Tropical de São Paulo da Universidade de São Paulo
Av. Dr. Enéas de Carvalho Aguiar, 470. Prédio 1 – Andar térreo.
05403-000 São Paulo, SP, Brazil.
Telephone: 5511 3061-7003   -   Fax: 5511 3062-2174
The Library of the São Paulo Institute of Tropical Medicine (IMTSP Library) was created on January 
15, 1959 in order to serve all those who are interested in tropical diseases. To reach this objective, we 
select and acquire by donation and / or exchange appropriate material to be used by researchers and we 
maintain interchange between Institutions thorough the Journal of the São Paulo Institute of Tropical 
Medicine, since the Library has no funds to build its own patrimony.
The IMTSP Library has a patrimony consisting of books, theses, annals of congresses, journals, 
and reference works.
The collection fo journals existing in the Library can be verified through the USP – Bibliographic 
Database – OPAC – DEDALUS  http://dedalus.usp.br:4500/ALEPH/eng/USP/USP/DEDALUS/start 
of the USP network.
